Back
RxSight Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
23
RXST
RxSight
Last Price:
$24.69
Seasonality Move:
36.09%
Buy
52
SRPT
Sarepta Therapeutics
Last Price:
$73.63
Seasonality Move:
14.66%
Sell
23
RxSight (RXST)
is a Sell
Is RxSight a Buy, Sell or Hold?
-
RXST is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $76.33. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $76.33Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RXST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.63 | Sell |
| Relative Strength Index (14 RSI): | 32.67 | Sell |
| Chaikin Money Flow: | -286344 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.13 - 29.53) | Sell |
| Bollinger Bands (100): | (28.32 - 44.66) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.07 | Sell |
| Relative Strength Index (14 RSI): | 30.8 | Sell |
| Chaikin Money Flow: | 1304026 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (86.54 - 110.54) | Sell |
| Bollinger Bands (100): | (102.23 - 127.85) | Sell |
RXST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.35 | Sell |
| 20-day SMA: | 26.48 | Sell |
| 50-day SMA: | 29.91 | Sell |
| 200-day SMA: | 44.34 | Sell |
| 8-day EMA: | 25.33 | Sell |
| 20-day EMA: | 26.66 | Sell |
| 50-day EMA: | 30.09 | Sell |
| 200-day EMA: | 39.7 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.29 | Sell |
| 20-day SMA: | 96.26 | Sell |
| 50-day SMA: | 107.61 | Sell |
| 200-day SMA: | 124.92 | Sell |
| 8-day EMA: | 82.75 | Sell |
| 20-day EMA: | 92.99 | Sell |
| 50-day EMA: | 104.03 | Sell |
| 200-day EMA: | 117.97 | Sell |
RxSight Earnings Growth & RXST Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.36 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
RxSight Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||